Search
Patexia Research
Case number 1:22-cv-01461

Amicus Therapeutics US, LLC et al v. Teva Pharmaceuticals USA, Inc. et al > Summary

Court Case Number 1:22-cv-01461

Filing Date Nov 7, 2022

Court Delaware District Court

Status Unknown

JudgesMichael A. Shipp, Colm F. Connolly

Plaintiff Attorneys

22

Amicus Therapeutics, Inc.
Attorney Name: Chad S. C. Stover
Barnes & Thornburg LLP

Amicus Therapeutics, Inc.
Attorney Name: Anna Marie T. Whitacre
Barnes & Thornburg LLP

Amicus Therapeutics, Inc.
Attorney Name: Christina M. Baugh
Barnes & Thornburg LLP

Amicus Therapeutics, Inc.
Attorney Name: Heather B. Repicky
Barnes & Thornburg LLP

Amicus Therapeutics, Inc.
Attorney Name: John W. Cox
Barnes & Thornburg LLP

Amicus Therapeutics, Inc.
Attorney Name: Joshua M. Kalb
Barnes & Thornburg LLP

Amicus Therapeutics, Inc.
Attorney Name: Joshua E. Ney
Barnes & Thornburg LLP

Amicus Therapeutics, Inc.
Attorney Name: Lauren Baker
Barnes & Thornburg LLP

Amicus Therapeutics, Inc.
Attorney Name: Mark C. Nelson
Barnes & Thornburg LLP

Amicus Therapeutics, Inc.
Attorney Name: Karen Ann Jacobs
Morris Nichols Arsht & Tunnell

Amicus Therapeutics, Inc.
Attorney Name: Allison C. Penfield
Groombridge, Wu, Baughman & Stone LLP

Amicus Therapeutics, Inc.
Attorney Name: Cameron P. Clark
Morris Nichols Arsht & Tunnell

Amicus Therapeutics, Inc.
Attorney Name: Jennifer Rea Deneault
Groombridge, Wu, Baughman & Stone LLP

Amicus Therapeutics, Inc.
Attorney Name: Jennifer H. Wu
Groombridge, Wu, Baughman & Stone LLP

Amicus Therapeutics, Inc.
Attorney Name: Josephine Sue Young
Groombridge, Wu, Baughman & Stone LLP

Amicus Therapeutics, Inc.
Attorney Name: Kyle N. Bersani
Groombridge, Wu, Baughman & Stone LLP

Amicus Therapeutics, Inc.
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell

Amicus Therapeutics, Inc.
Attorney Name: Naz E. Wehrli
Groombridge, Wu, Baughman & Stone LLP

Amicus Therapeutics, Inc.
Attorney Name: Nicholas P. Groombridge
Groombridge, Wu, Baughman & Stone LLP

Amicus Therapeutics, Inc.
Attorney Name: Peter Sandel
Groombridge, Wu, Baughman & Stone LLP

Amicus Therapeutics, Inc.
Attorney Name: Stephen A. Maniscalco
Groombridge, Wu, Baughman & Stone LLP

Defendant Attorneys

23

Teva Pharmaceuticals
Attorney Name: Kurt A. Mathas
Winston & Strawn

Teva Pharmaceuticals
Attorney Name: Tyree M. Petty-Williams
Winston & Strawn

Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP

Lupin Limited
Attorney Name: John C. Phillips Jr.
Phillips, McLaughlin & Hall, P.A.

Lupin Limited
Attorney Name: Amy M. Lange Miller
Troutman Pepper Locke LLP

Lupin Limited
Attorney Name: David A. Bilson
Phillips, McLaughlin & Hall, P.A.

Lupin Limited
Attorney Name: Jacob C. Britz
Troutman Pepper Locke LLP

Lupin Limited
Attorney Name: Jonathan B. Turpin
Troutman Pepper Locke LLP

Lupin Limited
Attorney Name: Keith D. Parr
Troutman Pepper Locke LLP

Lupin Limited
Attorney Name: Nina J. Vachhani
Troutman Pepper Locke LLP

Aurobindo Pharma USA
Attorney Name: R. Touhey Myer
Kratz & Barry

Aurobindo Pharma USA
Attorney Name: Michael P. Hogan
Kratz & Barry

Aurobindo Pharma USA
Attorney Name: Timothy H. Kratz
Kratz & Barry

Teva Pharmaceuticals
Attorney Name: Ashley Marie Graham
Winston & Strawn

Teva Pharmaceuticals
Attorney Name: Kevin J. Boyle
Winston & Strawn

Aurobindo Pharma USA
Attorney Name: George J. Barry III
Kratz & Barry

Teva Pharmaceuticals
Attorney Name: Noorossadat Torabi
Winston & Strawn

Teva Pharmaceuticals
Attorney Name: Emily S. Dibenedetto
Shaw Keller LLP

Lupin Limited
Attorney Name: Amy M. Lange Miller
Buchanan Ingersoll & Rooney PC

Lupin Limited
Attorney Name: Jacob C. Britz
Buchanan Ingersoll & Rooney PC

Lupin Limited
Attorney Name: Jonathan B. Turpin
Buchanan Ingersoll & Rooney PC

Lupin Limited
Attorney Name: Keith D. Parr
Buchanan Ingersoll & Rooney PC

Related Patents

Doc No Title Issue date
11903938 Methods of treating Fabry patients having renal impairment Feb 20, 2024
11813255 Methods of treating Fabry patients having renal impairment Nov 14, 2023
11786516 Methods of treating Fabry patients having renal impairment Oct 17, 2023
11642334 Methods of treating Fabry patients having renal impairment May 9, 2023
11633388 Methods of treating Fabry patients having renal impairment Apr 25, 2023
11633387 Methods of treating Fabry patients having renal impairment Apr 25, 2023
11622962 Methods of treating Fabry patients having renal impairment Apr 11, 2023
11612594 Methods of treating Fabry patients having renal impairment Mar 28, 2023
11612593 Methods of treating Fabry patients having renal impairment Mar 28, 2023
11458128 Methods of treating Fabry patients having renal impairment Oct 4, 2022
11426396 Methods of treating Fabry patients having renal impairment Aug 30, 2022
11389437 Methods of treating Fabry patients having renal impairment Jul 19, 2022
11389436 Methods of treating fabry patients having renal impairment Jul 19, 2022
11376244 Methods of treating Fabry patients having renal impairment Jul 5, 2022
11357784 Use of migalastat for treating Fabry disease in pregnant patients Jun 14, 2022
11357765 Methods of treating Fabry patients having renal impairment Jun 14, 2022
11357764 Methods of treating Fabry patients having renal impairment Jun 14, 2022
11357763 Methods of treating fabry patients having renal impairment Jun 14, 2022
11357762 Methods of treating Fabry patients having renal impairment Jun 14, 2022
11357761 Methods of treating Fabry patients having renal impairment Jun 14, 2022
11304940 Methods of treating Fabry patients having renal impairment Apr 19, 2022
11278540 Methods of treating Fabry patients having renal impairment Mar 22, 2022
11278539 Methods of treating Fabry patients having renal impairment Mar 22, 2022
11278538 Methods of treating Fabry patients having renal impairment Mar 22, 2022
11278537 Methods of treating Fabry patients having renal impairment Mar 22, 2022
11278536 Methods of treating Fabry patients having renal impairment Mar 22, 2022
11241422 Methods for treatment of Fabry disease Feb 8, 2022
11234972 Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene Feb 1, 2022
11033538 Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones Jun 15, 2021
10925866 Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones Feb 23, 2021
10874657 Methods of treating Fabry patients having renal impairment Dec 29, 2020
10874656 Methods of treating Fabry patients having renal impairment Dec 29, 2020
10874655 Methods of treating fabry patients having renal impairment Dec 29, 2020
10857142 Methods of treating Fabry patients having renal impairment Dec 8, 2020
10857141 Methods of treating Fabry patients having renal impairment Dec 8, 2020
10849890 Methods of treating Fabry patients having renal impairment Dec 1, 2020
10849889 Methods of treating Fabry patients having renal impairment Dec 1, 2020
10813921 Method to predict response to pharmacological chaperone treatment of diseases Oct 27, 2020
10806727 Methods of treating fabry patients having renal impairment Oct 20, 2020
10799491 Methods of treating Fabry patients having renal impairment Oct 13, 2020
10792279 Methods of treating Fabry patients having renal impairment Oct 6, 2020
10792278 Methods of treating Fabry patients having renal impairment Oct 6, 2020
10525045 Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones Jan 7, 2020
10471053 Methods of treating Fabry patients having renal impairment Nov 12, 2019
10406143 Methods for treatment of fabry disease Sep 10, 2019
10383864 Methods for treatment of Fabry disease Aug 20, 2019
10251873 Methods of treating fabry patients having renal impairment Apr 9, 2019
10076514 Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene Sep 18, 2018
09999618 Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones Jun 19, 2018
09987263 Methods for treatment of Fabry disease Jun 5, 2018
09480682 Methods for treatment of Fabry disease Nov 1, 2016
09095584 Method to predict response to pharmacological chaperone treatment of diseases Aug 4, 2015
09000011 Methods for treatment of Fabry disease Apr 7, 2015
08592362 Method to predict response to pharmacological chaperone treatment of diseases Nov 26, 2013
Menu